Privately-held UK biotech Curve Therapeutics today announced the further strengthening of its leadership team with the appointments of Andre Hoekema as chairman of the board and Cora Griffin as head of business development. 2 October 2024
NK:IO, a London startup developing a cell therapy for treating solid tumors, has announced the appointment of a permant chief executive and the finalization of a seed funding round. 2 October 2024
Halda Therapeutics, a US biotech company advancing cancer treatments, announced the appointment of Christian Schade as president and chief executive. 1 October 2024
AstronauTx, a biotech developing novel treatments for Alzheimer's disease and other neurodegenerative disorders, has announced the appointment of Jane Rhodes as chief executive officer. 1 October 2024
USA-based engineered regulatory T cells (Tregs) company GentiBio today announced the appointment of Dr Mark Bach as chief medical officer. 30 September 2024
Recently-created by US biotech incubator Flagship Pioneering, Abiologics has announced the appointment of Maria-Chiara Magnone as its chief scientific officer. 26 September 2024
German privately-held biotech ARTCLINE Bio-Therapies today announced the appointment of Dirk Hessel as additional managing director of the company. 23 September 2024
Stalicla, a privately-held Swiss biotech, today announced that Dr Paulo Fontoura will be joining its drug development team as chief scientific and clinical development advisor. 19 September 2024
US contract development and manufacturing organization (CDMO) BioCentriq has appointed Syed Husain as its new chief executive (CEO), and as a member of the board of directors. 19 September 2024
Californian biopharma 89bio, a company focused on the development and commercialization of innovative therapies for the treatment of liver and cardiometabolic diseases, has announced an important appointment. 17 September 2024
British biotech IMU Biosciences has announced key changes to its leadership team as it looks to grow in the field of precision medicine. 17 September 2024
Ohio, USA-based Trailhead Biosystems has appointed Josh Snow as its new chief commercial officer, as the company moves to expand its presence in the commercial market with its iPSC-derived human cell products. 16 September 2024
US neurological diseases specialist Ovid Therapeutics has announced the promotion of Meg Alexander to president and chief operating officer (COO). 12 September 2024
French cancer focused biotech Transgene has appointed two seasoned leaders in oncology who will be instrumental in advancing the company’s innovative immunotherapy programs 10 September 2024
Italy-based biotech AAVantgarde Bio has appointed Jayashree Sahni as its new chief medical officer, replacing Naveed Shams, who has held the role since 2022. 10 September 2024
In a filing with the US Securities and Exchange Commission (SEC), bluebird bio has announced the departure of its chief medical officer, David Davidson. 17 March 2021
Belgium’s AgomAb Therapeutics says it has closed a $74 million Series B financing round led by Redmile Group, which will further advance its lead compound AGMB-101. 10 March 2021
Parisian biotech Advicenne has provided a business update, highlighting a recent positive scientific opinion for lead medicine ADV7103 (potassium citrate/potassium hydrogen carbonate) in Europe. 19 February 2021
A new pharmaceutical R&D model was created today, with the merger of 10 privately-held biotech companies with highly validated programs led by industry leading teams to operate under the Centessa umbrella. 17 February 2021
Japanese drugmaker Astellas Pharma has boosted its senior management team, creating two new positions which will report directly to chief executive Kenji Yasukawa. 5 February 2021
Francesco Marincola will join Kite as senior vice president and global head of cell therapy research, effective February 1, said the biotech firm. 19 January 2021
US biotech Novavax today announced the appointment of Henrietta Ukwu to the position of senior vice president, chief regulatory and quality officer. 15 January 2021
AskBio says that Katherine High has joined the company in the newly-formed role of president, therapeutics, and will also serve on its board of directors. 13 January 2021
USA-based biotech firm bluebird bio has announced a plan to split into two separate companies, with one focusing on severe genetic disease and another on oncology. 12 January 2021
Innocoll Holdings, a specialty pharma company wholly-owned by Gurnet Point Capital, a private investment firm focused on health care, has named Louis Pascarella its new chief executive. 11 January 2021
Austrian antiviral vaccine and immunodiagnostics specialist Viravaxx has appointed Helmut Brunar, former CEO and chairman at Axentis Pharma, as chief executive officer. 11 January 2021
German privately-held vascular integrity company Adrenomed today revealed that Wolfgang Baiker has been appointed as chief executive (CEO) effective January 1, 2021. 4 January 2021
US privately-held immunotherapy company ImmunityBio has appointed Fabio Benedetti as chief strategy officer, effective January 4, 2021. 31 December 2020
South Korean contract development and manufacturing organization Samsung Biologics says that John Rim will become its president and chief executive, with immediate effect. 17 December 2020